AGP Executive Report
Last update: 5 hours agoHealth Tech & IP: Island Pharmaceuticals secured a Singapore patent for ISLA-101’s use against flavivirus infections, expanding protection beyond dengue to include chikungunya, with coverage until April 2034—boosting prospects for future licensing as the antiviral candidate advances. Public Health & Climate: Singapore warns haze could turn “severe” in August and September due to El Niño-linked dry conditions, advising N95 masks for those outdoors for long periods. Healthcare Capacity: Sarawak pushes to establish its first medical faculty at UTS to tackle a shortage of about 2,000 doctors and specialists, with a feasibility study submitted to the state government. Digital Health & Wellness: Singapore expands AI and digital support for retail SMEs, while a separate Singapore development highlights an AI tool that can analyse heart attack damage in about a minute. Workplace Health & Safety: Singapore tightens timber scaffold rules to reduce fire risk after a major blaze, and SCDF will end the non-emergency ambulance hotline in 2027. Local Health Economy: Foundation Healthcare filed for a S$242m SGX IPO to expand specialist practices and medical centres. Mosquito-Borne Disease Focus: The ISLA-101 patent adds momentum in the fight against mosquito-borne illnesses with limited antiviral options.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
Pseudo-journalism: Pink-slime
